• / Free eNewsletters & Magazine
  • / My Account
Home>Investing Topics>Regulation

Regulation

  1. All
  2. Morningstar Articles
  3. Videos
  4. 3rd Party
  5. Investing
  6. Research
  1. LDK Solar Requests Review of NYSE Regulation's Decision to Suspend Trading and Commence Delisting Procedures

    LDK Solar Requests Review of NYSE Regulation's Decision to Suspend Trading and Commence Delisting Procedures

  2. Neurovive Pharmaceutical: NeuroVive Presents Medical Breakthrough in Cellular Energy Regulation

    Neurovive Pharmaceutical: NeuroVive Presents Medical Breakthrough in Cellular Energy Regulation

  3. Albemarle reports first quarter 2014 results

    Albemarle reports first quarter 2014 results

  4. Tianli Agritech Redeems 40% Equity Interest in Operating Subsidiary from XMRJ

    Tianli Agritech Redeems 40% Equity Interest in Operating Subsidiary from XMRJ

  5. 1st United Bancorp, Inc. Announces Increased Earnings for the three months ended March 31, 2014

    1st United Bancorp, Inc. Announces Increased Earnings for the three months ended March 31, 2014

  6. UPDATE: Can the SEC fix target-date funds?

    UPDATE: Can the SEC fix target-date funds?

  7. Tecnoglass Announces 2013 Financial Results

    Tecnoglass Announces 2013 Financial Results

  8. Fitch Affirms Roundpoint Mortgage Servicing Corp's Residential Mtge Servicer Ratings; Outlook Stable

    Fitch Affirms Roundpoint Mortgage Servicing Corp's Residential Mtge Servicer Ratings; Outlook Stable

  9. FDA Approves Merck’s RAGWITEK™ (Short Ragweed Pollen Allergen Extract) Sublingual Tablet as Immunotherapy to Treat Short Ragweed Pollen-Induced Allergic Rhinitis with or without Conjunctivitis in ...

    FDA Approves Merck’s RAGWITEK™ (Short Ragweed Pollen Allergen Extract) Sublingual Tablet as Immunotherapy to Treat Short Ragweed Pollen-Induced Allergic Rhinitis with or without Conjunctivitis in Adults

  10. Lloyds Banking Group PLC ECN Retail Tender Offer -2-

    Lloyds Banking Group PLC ECN Retail Tender Offer -2-

12345
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.